Microtubule is one of the key components of the cytoskeleton and plays an important role in the maintenance of cell shape and the process of signal transduction and mitosis.  Due to the extreme importance  of microtubule in the process of mitosis, tubulin becomes one of the most important targets for development of new anticancer drugs and tubulin inhibitors are used for the treatment of cancer nowadays.  These inhibitors have antitumor activity by inhibiting or promoting the assembly of tubulin to microtubules and interfering the process of cell mitosis.  This review summarized the research progress of the tublulin inhibitors, especially the introduction of the tubulin inhibitors of pharmacological activities and the progress of clinical research.  Also, the development trend of these inhibitors is discussed.